Protein kinase A-Iα subunit-directed antisense inhibition of ovarian cancer cell growth: crosstalk with tyrosine kinase signaling pathway
- 2 September 1999
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 18 (35) , 4999-5004
- https://doi.org/10.1038/sj.onc.1202830
Abstract
Expression of the RIα subunit of cAMP-dependent protein kinase type I is increased in human cancers in which an autocrine pathway for epidermal growth factor-related growth factors is activated. We have investigated the effect of sequence-specific inhibition of RIα gene expression on ovarian cancer cell growth. We report that RIα antisense treatment results in a reduction in RIα expression and protein kinase A type I, and inhibition of cell growth. The growth inhibition was accompanied by changes in cell morphology and appearance of apoptotic nuclei. In addition, EGF receptor, c-erbB-2 and c-erbB-3 levels were reduced, and the basal and EGF-stimulated mitogen-activated protein kinase activities were reduced. Protein kinase A type I and EGF receptor levels were also reduced in cells overexpressing EGF receptor antisense cDNA. These results suggest that the antisense depletion of RIα leads to blockade of both the serine-threonine kinase and the tyrosine kinase signaling pathways resulting in arrest of ovarian cancer cell growth.Keywords
This publication has 26 references indexed in Scilit:
- Down-regulation of type I protein kinase A by transfection of human breast cancer cells with an epidermal growth factor receptor antisense expression vectorBreast Cancer Research and Treatment, 1998
- Antisense—Protein Kinase A: A Single-Gene-Based Therapeutic ApproachAntisense and Nucleic Acid Drug Development, 1997
- Protein Kinase A-Directed Antisense Restrains Cancer Growth: Sequence-Specific Inhibition of Gene ExpressionAntisense and Nucleic Acid Drug Development, 1996
- Point mutation of the autophosphorylation site or in the nuclear location signal causes protein kinase A RII beta regulatory subunit to lose its ability to revert transformed fibroblasts.Proceedings of the National Academy of Sciences, 1995
- Suppression of Ras-Induced Transformation of NIH 3T3 Cells by Activated Gα SScience, 1994
- Inhibition by cAMP of Ras-Dependent Activation of RafScience, 1993
- Growth Factors and CancerScience, 1991
- 8-Chloro-cAMP inhibits transforming growth factor alpha transformation of mammary epithelial cells by restoration of the normal mRNA patterns for cAMP-dependent protein kinase regulatory subunit isoforms which show disruption upon transformation.Published by Elsevier ,1990
- Site-Selective Cyclic AMP Analogs as New Biological Tools in Growth Control, Differentiation, and Proto-oncogene RegulationCancer Investigation, 1989
- Phosphorylation-Dephosphorylation of EnzymesAnnual Review of Biochemistry, 1979